Some early data suggested it might actually promote fat storage
The complaints also allege that the touted studies are on individual ingredients and do not actually measure the extracts together in a single supplement, so that while they claim to have clinical support for the components of Lemme GLP-1 Daily, they did not study the combination of those extracts in a single supplementmeaning that the supplement has not been clinically tested. Many courts, including those in New York and California, preclude private individuals from challenging advertising based on the advertiser lacking adequate substantiation for their claims, as the plaintiffs have done in the Lemme complaints
The Impact of Modern Part D Cost Caps A massive, positive shift occurred in the structure of Medicare prescription drug costs due to recent federal legislation
statistically significant improvement in motor symptoms Another trial with once-daily self-administered injections of liraglutide (1.2 or 1.8 mg, as tolerated) or placebo in 62 patients with PD reported improvements in MDS-UPDRS-2 (an activity of daily living scale), but not in MDS-UPDRS-3, in treated patients vs placebo
In a real-world analysis of individuals with history of opioid use disorder and alcohol use disorder (AUD), published in Addiction last October, researchers reported that GLP-1 receptor agonists and similar drugs for diabetes and weight-related conditions were associated with a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication in people with opioid use disorder and AUDs, respectively
